ChiCTR2400082512 版本V1.0 版本创建时间2024/03/31 17:47:58 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2400082512 

最近更新日期:

Date of Last Refreshed on:

2024-03-31 17:47:52 

注册时间:

Date of Registration:

2024-03-31 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

0-3岁不同发育年龄段孤独症谱系障碍儿童的共同注意力特点分析

Public title:

Analysis of joint attention characteristics in 0-3 years old children with autism spectrum disorder in different developmental ages

注册题目简写:

English Acronym:

研究课题的正式科学名称:

0-3岁不同发育年龄段孤独症谱系障碍儿童的共同注意力特点分析

Scientific title:

Analysis of joint attention characteristics in 0-3 years old children with autism spectrum disorder in different developmental ages

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

陈玉美 

研究负责人:

陈玉美 

Applicant:

CHEN Yumei 

Study leader:

CHEN Yumei 

申请注册联系人电话:

Applicant telephone:

+86 20 6278 6251

研究负责人电话:

Study leader's
telephone:

+86 158 0203 3759

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

562538660@qq.com

研究负责人电子邮件:

Study leader's E-mail:

562538660@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

广东省广州市白云区广州大道北1838号南方医院

研究负责人通讯地址:

广东省广州市白云区广州大道北1838号南方医院

Applicant address:

Nanfang Hospital, 1838 Guangzhou Avenue North, Baiyun District, Guangzhou City, Guangdong Province

Study leader's address:

Nanfang Hospital, 1838 Guangzhou Avenue North, Baiyun District, Guangzhou City, Guangdong Province

申请注册联系人邮政编码:

Applicant postcode:

501515

研究负责人邮政编码:

Study leader's postcode:

510515

申请人所在单位:

南方医科大学南方医院

Applicant's institution:

Nanfang Hospital, Southern Medical University

研究负责人所在单位:

南方医科大学南方医院

Affiliation of the Leader:

Nanfang Hospital, Southern Medical University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

NFEC-2021-321

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

南方医科大学南方医院医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee of Nanfang Hospital, Southern Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2021-09-30 00:00:00

伦理委员会联系人:

胡兴媛

Contact Name of the ethic committee:

HU Xingyuan

伦理委员会联系地址:

广东省广州市白云区广州大道北1838号南方医科大学南方医院

Contact Address of the ethic committee:

Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Baiyun District, Guangzhou City, Guangdong Province, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 20 6278 6251

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

南方医科大学南方医院

Primary sponsor:

Nanfang Hospital, Southern Medical University

研究实施负责(组长)单位地址:

广东省广州市白云区广州大道北1838号南方医科大学南方医院

Primary sponsor's address:

Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Baiyun District, Guangzhou City, Guangdong Province, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

广东

市(区县):

广州

Country:

China

Province:

Guangdong

City:

Guangzhou

单位(医院):

南方医科大学南方医院

具体地址:

广东省广州市白云区广州大道北1838号南方医科大学南方医院

Institution
hospital:

Nanfang Hospital, Southern Medical University

Address:

Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Baiyun District, Guangzhou City, Guangdong Province, China

经费或物资来源:

南方医科大学南方医院

Source(s) of funding:

Nanfang Hospital, Southern Medical University

研究疾病:

孤独症谱系障碍  

Target disease:

Autism spectrum disorder

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

横断面 

Study design:

Cross-sectional 

研究目的:

①观察孤独症谱系障碍儿童的共同注意力 ②观察共同注意能力与发育年龄、社交、语言能力之间的关系  

Objectives of Study:

①The joint attention of children with autism spectrum disorder was observed ②To observe the relationship between joint attention ability and developmental age, social and language ability

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

①根据美国精神障碍诊断统计手册第五版的诊断标准,诊断为孤独症谱系障碍的患者;②儿童孤独症评定量表(childhood autism rating scale, CARS)>=30分;③生理年龄在2-6岁;④发育年龄在0-3岁; ⑤监护人同意参与本研究。

Inclusion criteria

① Patients diagnosed with autism spectrum disorder according to the Diagnostic criteria of the Diagnostic Statistical Manual of Mental Disorders, Fifth Edition; ②childhood autism rating scale (CARS) >=30 points; ③ The biological age is 2-6 years old; ④ The developmental age is 0-3 years old; ⑤ The guardian agrees to participate in this study.

排除标准:

①合并有神经系统器质性疾病的患者。②不能完成测试者。

Exclusion criteria:

① Patients with organic diseases of the nervous system.② Unable to complete the test.

研究实施时间:

Study execute time:

From 2021-01-01 00:00:00 To 2025-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2024-04-01 00:00:00 To 2024-12-22 00:00:00

干预措施:

Interventions:

组别:

发育年龄0-6月

样本量:

15

Group:

Developmental age 0-6 months

Sample size:

干预措施:

干预措施代码:

Intervention:

none

Intervention code:

组别:

发育年龄6-12月

样本量:

15

Group:

Development age 6-12 months

Sample size:

干预措施:

干预措施代码:

Intervention:

none

Intervention code:

组别:

发育年龄12-18月

样本量:

15

Group:

Development age 12-18 months

Sample size:

干预措施:

干预措施代码:

Intervention:

none

Intervention code:

组别:

发育年龄18-24月

样本量:

15

Group:

Development age 18-24 months

Sample size:

干预措施:

干预措施代码:

Intervention:

none

Intervention code:

组别:

发育年龄24-30月

样本量:

15

Group:

The developmental age 24-30 months

Sample size:

干预措施:

干预措施代码:

Intervention:

none

Intervention code:

组别:

发育年龄30-36月

样本量:

15

Group:

The developmental age 30-36 months

Sample size:

干预措施:

干预措施代码:

Intervention:

none

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

广东 

市(区县):

 

Country:

China

Province:

Guangdong

City:

单位(医院):

南方医科大学南方医院 

单位级别:

三甲 

Institution
hospital:

Nanfang Hospital, Southern Medical University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

共同注意力

指标类型:

主要指标

Outcome:

Joint attention ability

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

发育年龄

指标类型:

次要指标

Outcome:

developmental age

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

社交能力

指标类型:

次要指标

Outcome:

social ability

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

语言能力

指标类型:

次要指标

Outcome:

language competence

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 2 years
最大 Max age 6 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

None

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

采用病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form will be used

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2024-03-31 17:47:52